首页> 外文期刊>Infection control and hospital epidemiology >Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.
【24h】

Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.

机译:在手术重症监护病房中尝试使用浸有润肤剂的手套来普及手套,以促进皮肤健康并防止耐多药生物体的传播。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To compare the efficacy of universal gloving with emollient-impregnated gloves with standard contact precautions for the control of multidrug-resistant organisms (MDROs) and to measure the effect on healthcare workers' (HCWs') hand skin health. DESIGN: Prospective before-after trial. SETTING: An 18-bed surgical intensive care unit. METHODS: During phase 1 (September 2007 through March 2008) standard contact precautions were used. During phase 2 (March 2008 through September 2008) universal gloving with emollient-impregnated gloves was used, and no contact precautions. Patients were screened for vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). HCW hand hygiene compliance and hand skin health and microbial contamination were assessed. The incidences of device-associated infection and Clostridium difficile infection (CDI) were determined. RESULTS: The rate of compliance with contact precautions (phase 1) was 67%, and the rate of compliance with universal gloving (phase 2) was 78% (P = .01). Hand hygiene compliance was higher during phase 2 than during phase 1 (before patient care, 40% vs 35% of encounters; P = .001; after patient care, 63% vs 51% of encounters; P < .001). No difference was observed in MDRO acquisition. During phases 1 and 2, incidences of device-related infections, in number of infections per 1,000 device-days, were, respectively, 3.7 and 2.6 for bloodstream infection (P = .10), 8.9 and 7.8 for urinary tract infection (P = .10), and 1.0 and 1.1 for ventilator-associated pneumonia (P = .09). The CDI incidence in phase 1 and in phase 2 was, respectively, 2.0 and 1.4 cases per 1,000 patient-days (P = .53). During phase 1, 29% of HCW hand cultures were MRSA positive, compared with 13% during phase 2 (P = .17); during phase 1, 2% of hand cultures were VRE positive, compared with 0 during phase 2 (P = .16). Hand skin health improved during phase 2. CONCLUSIONS: Compared with contact precautions, universal gloving with emollient-impregnated gloves was associated with improved hand hygiene compliance and skin health. No statistically significant change in the rates of device-associated infection, CDI, or patient MDRO acquisition was observed. Universal gloving may be an alternative to contact precautions.
机译:目的:比较通用手套与浸有润肤剂的手套与标准接触预防措施对控制耐多药生物(MDRO)的功效,并测量其对医护人员(HCW)手皮肤健康的影响。设计:前瞻性试用。地点:拥有18张床的外科重症监护室。方法:在第一阶段(2007年9月至2008年3月),使用了标准的接触预防措施。在第2阶段(2008年3月至2008年9月),使用了浸有润肤剂的通用手套,并且没有接触预防措施。筛选患者的耐万古霉素肠球菌(VRE)和耐甲氧西林金黄色葡萄球菌(MRSA)。评估了医护人员手卫生的依从性,手皮肤健康和微生物污染。确定了设备相关感染和艰难梭菌感染(CDI)的发生率。结果:接触预防措施的遵守率(第一阶段)为67%,通用手套的遵守率(第二阶段)为78%(P = 0.01)。在第二阶段中,手卫生依从性高于第一阶段(在患者护理之前,相遇次数占40%比35%; P = 0.001;在患者护理之后,相遇次数占63%对51%; P <.001)。在MDRO采集中未观察到差异。在第1阶段和第2阶段,与设备有关的感染的发生率(以每1,000个设备日的感染数计)分别为:血液感染的感染率分别为3.7和2.6(P = 0.10),尿路感染的感染率分别为8.9和7.8(P = .10),呼吸机相关性肺炎的1.0和1.1(P = .09)。第1阶段和第2阶段的CDI发生率分别为每1,000个患者日2.0例和1.4例(P = 0.53)。在第1阶段,HCW手工培养物中29%的MRSA阳性,而在第2阶段中则为13%(P = .17);在第1阶段,手培养的2%为VRE阳性,而在第2阶段为0(P = .16)。在第2阶段中,手部皮肤的健康状况得到改善。结论:与接触预防措施相比,使用浸有润肤剂的手套进行全指手套与改善手部卫生和皮肤健康有关。没有观察到与设备相关的感染,CDI或患者MDRO获得率的统计学显着变化。通用手套可以代替接触预防措施。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号